GlassScriptPhysician profile
James Booth Mcguire
NPI 1942295829
$60,331.97
in general payments reported to CMS, 2019-2025
32 companies · $833 in 2025
The $833 reported for 2025 was more than what 76% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $8,001 · 2021: $9,077 · 2022: $16K · 2023: $2,421 · 2024: $644 · 2025: $833.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,149 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,148.93 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $28,015.67 | 2019-2025 | Collagenase Santyl, Grafix Pl, Stravix Mesh |
| Reapplix INC. | $14,237.12 | 2020-2023 | 3c Patch Kit - Box |
| Bsn Medical INC | $12,512.26 | 2019-2024 | |
| Musculoskeletal Transplant Foundation INC. | $1,850.16 | 2020-2021 | |
| Osiris Therapeutics INC. | $1,645.62 | 2019 | |
| Kerecis Limited | $694.79 | 2019-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Surgiclose |
| Paratek Pharmaceuticals, INC. | $166.94 | 2021-2024 | Nuzyra |
| Zimmer Biomet Holdings, INC. | $165.38 | 2024 | |
| Medline Industries LP | $149.08 | 2019 | |
| Tactile Systems Technology INC | $144.78 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $90.68 | 2019-2025 | |
| Organogenesis INC. | $81.45 | 2019-2022 | |
| Leo Pharma INC. | $62.95 | 2025 | Spevigo |
| Averitas Pharma INC. | $53.21 | 2025 | Qutenza |
| Celgene Corporation | $45.23 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sebela Pharmaceuticals INC. | $43.63 | 2019 | |
| Nevro Corp. | $36.96 | 2022 | |
| Medtronic, INC. | $35.00 | 2023 | Intellis Adaptivestim |
| Integra Lifesciences Corporation | $33.66 | 2022 | |
| Solventum Corporation | $30.86 | 2025 | Activ.A.C. |
| Hartmann USA, INC. | $24.70 | 2025 | Zetuvit Plus 10x10 P10 |
| Lifenet Health | $24.29 | 2025 | Theragenesis Wound Matrix |
| Vertex Pharmaceuticals Incorporated | $22.95 | 2025 | |
| Polarityte, INC. | $22.15 | 2019 | |
| Btg International INC. | $21.96 | 2025 | Aurlumyn |
| Kci USA, INC. | $21.47 | 2020 | |
| Hydrofera LLC | $20.50 | 2023 | Hydrofera Blue |
| Melinta Therapeutics, LLC | $19.41 | 2019 | |
| Mimedx Group, INC. | $16.54 | 2024 | |
| Polynovo North America LLC | $14.81 | 2022 | |
| Misonix INC | $14.37 | 2019 | |
| Convatec INC. | $13.39 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Mcguire listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.